The University of Chicago Header Logo

Connection

Jeremy Segal to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications Jeremy Segal has written about Lymphoma, Non-Hodgkin.
Jeremy Segal
Connection Strength
0.136
Lymphoma, Non-Hodgkin
  1. Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019 02 15; 25(4):1174-1184.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.